SlideShare a Scribd company logo
1 of 44
Any of the highly specific antibodies produced in lar
ge quantity by the clones of a single hybridoma cell.
Monoclonal antibodies (mAb or moAb)
are monospecific antibodies that are made by
identical immune cells that are all clones of a unique
parent cell. Monoclonal antibodies
have monovalent affinity, in that they bind to the
same epitope.
 Antibodies have important uses beyond fighting
infections in the body.
 Production of long-lasting monoclonal antibodies is a
recent invention and it is used in both medicine and
research.
 Monoclonal Antibody: a stable antibody which can be
used over a period of time
1. Inject a mouse with a specific antigen to stimulate its
immune system to produce necessary antibodies.
2. Extract mouse spleen cells (containing B-
lymphocytes) and culture them in the lab.
3. Extract mouse tumour cells, which grow continuously,
and culture them in the lab.
4. Mix spleen cells and tumour cells on the same plate
and culture.
5. Add polyethylene glycol – this causes some B-
lymphocytes to fuse with tumour cells to
produce a hybrid cell called a hybridoma.
6. Grow the cells under conditions that allow only
hybridoma cells to survive.
7. Extract the cells, culture them separately and test
the medium around each cell for the specific
antibody of interest.
8. Culture the cells making the desired antibody
and use as needed.
 The previous picture is showing a mouse being immunized against a target cell
“X”. This will allow the mouse to produce antibodies for that will target against the
“X” antigen.
 Once the mouse has formed antibodies to the “X” antigen the cells are then isolated
in the mouse’s spleen. Monoclonal antibodies are produced by fusing single
antibody-forming cells to tumor cells grown in culture. The resulting cell is called a
hybridoma. Hybridoma cells are continuously growing cell line generated by the
fusion of a myeloma cell and a normal cell that are capable of producing
antibodies.
 Each hybridoma will produce relatively large quantities of identical antibody
molecules. Because the hybridoma is multiplying in culture, it is possible to
produce a population of cells, each is producing identical antibody molecules.
These antibodies are called "monoclonal antibodies" because they are produced by
the identical offspring of a single, cloned antibody producing cell.
 A pregnant woman has the hormone human chorionic
gonadotrophin (HCG) in her urine.
 Monoclonal antibodies to HCG have been produced.
These have been attached to enzymes which can later
interact with a dye molecule and produce a color
change.
 Pregnancy test contains three regions – reaction
region, test region and control region
◦ Reaction region: contains monoclonal anti-HCG antibodies
linked to enzyme
◦ Test region: contains polyclonal anti-HCG antibodies,
which will bind to HCG molecules bound to monoclonal
anti-HCG antibodies. Also contains dye molecules which
will be activated if monoclonal antibodies bind to polyclonal
anti-HCG antibodies
◦ Control region: contains anti-mouse antibodies and dye
molecules which will be activated if monoclonal antibodies
bind here
 When pregnant woman’s urine travels up the
pregnancy test, HCG will bind to monoclonal
antibodies in reaction region
 Movement of the urine will move the monoclonal
antibodies up to the test region
 Monoclonal antibodies with bound HCG will bind to
antibodies in test region and activate dye molecules,
producing a colour change
 Any unbound monoclonal antibodies will continue to
travel to control region and will bind to anti-mouse
antibodies, activating dye molecules and producing a
colour change
 The test of HIV infection
is based on detecting the
presence of HIV
antibody in the patient’s
blood serum.
a) HIV antigen is attached to the plate.
b) Patients serum passed over the plate. Any HIV
antibody in the patients serum will be attached to the
antigen already on the plate.
c) A second antibody which is specific to the HIV
antibody is passed over the plate. This antibody will
attach to the concentrated HIV antibody on the plate.
This second antibody has an enzyme attached to its
structure.
d) Chromogen dye is passed over the complex of
concentrated HIV antibody/conjugated antibody.
e) The enzyme will turn the chromogen to a more
intense color. The more intense the color, the greater
the HIV antibody level. This would be the a positive
result for a HIV test.
 Cancer cells carry specific tumour-associated antigens
(TAA) on their plasma membrane.
 Monoclonal anti-TAA antibodies have been produced.
 Drugs which kill tumour cells or inhibit key proteins in
tumour cells are attached to monoclonal anti-TAA
antibodies.
 Cancer cells are specifically targeted, avoiding damage
to healthy host cells.
 Many patients develop the immune response to
monoclonal antibodies produced in mice, as these are
foreign proteins.
 Genetically engineered antibodies are being perfected
to avoid triggering the immune response.
Stem Cells
1998 - Researchers first extract stem cells from human embryos
1999 - First Successful human transplant of insulin-making cells
from cadavers
2001 - President Bush restricts federal funding for embryonic
stem-cell research
2002 - Juvenile Diabetes Research Foundation International
creates $20 million fund-raising effort to support stem-cell
research
2002 - California ok stem cell research
2004 - Harvard researchers grow stem cells from embryos using
private funding
2004 - Ballot measure for $3 Billion bond for stem cells
Stem Cell History
 A cell that has the ability to continuously divide and
differentiate (develop) into various other kind(s) of
cells/tissues
 ‘Blank cells’ (unspecialized)
 Capable of dividing and renewing themselves for
long periods of time (proliferation and renewal)
 Have the potential to give rise to specialized cell
types (differentiation)
Stem cell
type Description Examples
Totipotent
Each cell can develop into
a new individual
Cells from early (1-3
days) embryos
Pluripotent
Cells can form any (over
200) cell types
Some cells of
blastocyst (5 to 14
days)
Multipotent
Cells differentiated, but
can form a number of other
tissues
Fetal tissue, cord
blood, and adult
stem cells
This cell
Can form the
Embryo and placenta
This cell
Can just form the
embryo
Fully mature
 Multipotent stem cells
– limited in what the
cells can become
Embryonic Stem Cells
Mainly from IVF
Why do researchers study embryonic
stem cells?
 Tissue-specific stem cells are limited in their
differentiation potential (blood  blood)
 Stem cells from some tissues are inaccessible
 Some tissue-specific stem cells don’t self-renew well
 Some tissues may not have stem cells!
blastocyst Blastocyst inner mass cells
8-cell stagecleavage
 Skin
 Fat Cells
 Bone marrow
 Brain
 Many other organs & tissues
Adult Stem Cells
An undifferentiated cells found among
specialized or differentiated cells in a tissue
or organ after birth
Induced Pluripotent Stem Cells
 Found in spongy bone where blood cells form
 Used to replace damaged or destroyed bone marrow with
healthy bone marrow stem cells.
 treat patients diagnosed with leukemia, aplastic anemia,
and lymphomas
 Need a greater histological immunocompatibility
Blood Cell Formation
 Also Known as Wharton’s Jelly
 Adult stem cells of infant origin
 Less invasive than bone marrow
 Greater compatibility
 Less expensive
Three important functions:
1. Plasticity: Potential to change into other
cell types like nerve cells
2. Homing: To travel to the site of tissue
damage
3. Engraftment: To unite with other
tissues
Stem Cell Applications
• Tissue repair
- nerve, heart, muscle, organ, skin
• Cancers
• Autoimmune diseases
- diabetes, rheumatoid arthritis, MS
Tissue Repair
• Regenerate spinal cord, heart tissue
or any other major tissue in the body.
Heart Disease
• Adult bone marrow stem cells injected
into the hearts are believed to improve
cardiac function in victims of heart
failure or heart attack
Leukemia and Cancer
• Studies show leukemia patients treated
with stem cells emerge free of disease.
• Injections of stem cells have also
reduces pancreatic cancers in some
patients.
Proliferation of white cells
Rheumatoid Arthritis
• Adult Stem Cells may be helpful in
jumpstarting repair of eroded cartilage.
Type I Diabetes
• Pancreatic cells do not produce insulin
• Embryonic Stems Cells might be
trained to become pancreatic islets cells
needed to secrete insulin.
• Differentiation of stem cells into
mature, functional cells
• Potential for tumor formation
• Immune rejection
 Embryonic Stem cells are derived from extra
blastocysts that would otherwise be discarded
following IVF.
 Extracting stem cells destroys the developing
blastocyst (embryo).
 Questions for Consideration-
 Is an embryo a person?
 Is it morally acceptable to use embryos for
research?
 When do we become “human beings?”
Thank You

More Related Content

What's hot

MONOCLONAL ANTIBODIES ( MAB )
MONOCLONAL ANTIBODIES ( MAB )MONOCLONAL ANTIBODIES ( MAB )
MONOCLONAL ANTIBODIES ( MAB )N Anusha
 
Production and applications of monoclonal antibodies
Production and applications of monoclonal antibodiesProduction and applications of monoclonal antibodies
Production and applications of monoclonal antibodiesKaayathri Devi
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technologyArchanaSoni3
 
Monoclonal antibodies
Monoclonal   antibodiesMonoclonal   antibodies
Monoclonal antibodiesPuja Saha
 
monoclonal antibodies in therapeutics
monoclonal antibodies in therapeuticsmonoclonal antibodies in therapeutics
monoclonal antibodies in therapeuticsSarju Zilate
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodiessaurav181087
 
Monoclonal Antibodies
Monoclonal AntibodiesMonoclonal Antibodies
Monoclonal AntibodiesAmeer Ahmed
 
Mabjeevan 141027001544-conversion-gate01
Mabjeevan 141027001544-conversion-gate01Mabjeevan 141027001544-conversion-gate01
Mabjeevan 141027001544-conversion-gate01kamal_1981
 
Monoclonal and Polyclonal antibodies
Monoclonal and Polyclonal antibodiesMonoclonal and Polyclonal antibodies
Monoclonal and Polyclonal antibodiesBiology Exams 4 U
 
Hybridoma Technology & its application in fisheries
Hybridoma Technology & its application in fisheriesHybridoma Technology & its application in fisheries
Hybridoma Technology & its application in fisheriesUday Das
 
Monoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody EngineeringMonoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody EngineeringARUNDHATI MEHTA
 
Aditya Monoclonal Antibodies
Aditya Monoclonal AntibodiesAditya Monoclonal Antibodies
Aditya Monoclonal AntibodiesP K ADITYA
 

What's hot (20)

MONOCLONAL ANTIBODIES ( MAB )
MONOCLONAL ANTIBODIES ( MAB )MONOCLONAL ANTIBODIES ( MAB )
MONOCLONAL ANTIBODIES ( MAB )
 
Mabs' drug
Mabs' drugMabs' drug
Mabs' drug
 
Production and applications of monoclonal antibodies
Production and applications of monoclonal antibodiesProduction and applications of monoclonal antibodies
Production and applications of monoclonal antibodies
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technology
 
Monoclonal antibodies
Monoclonal   antibodiesMonoclonal   antibodies
Monoclonal antibodies
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
monoclonal antibodies in therapeutics
monoclonal antibodies in therapeuticsmonoclonal antibodies in therapeutics
monoclonal antibodies in therapeutics
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Copy of monoclonal antibodies.doc seminar
Copy of monoclonal antibodies.doc seminarCopy of monoclonal antibodies.doc seminar
Copy of monoclonal antibodies.doc seminar
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Monoclonal Antibodies
Monoclonal AntibodiesMonoclonal Antibodies
Monoclonal Antibodies
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Mabjeevan 141027001544-conversion-gate01
Mabjeevan 141027001544-conversion-gate01Mabjeevan 141027001544-conversion-gate01
Mabjeevan 141027001544-conversion-gate01
 
Monoclonal and Polyclonal antibodies
Monoclonal and Polyclonal antibodiesMonoclonal and Polyclonal antibodies
Monoclonal and Polyclonal antibodies
 
Hybridoma Technology & its application in fisheries
Hybridoma Technology & its application in fisheriesHybridoma Technology & its application in fisheries
Hybridoma Technology & its application in fisheries
 
Antibodies as Drugs
Antibodies as DrugsAntibodies as Drugs
Antibodies as Drugs
 
Monoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody EngineeringMonoclonal Antibodies & Antibody Engineering
Monoclonal Antibodies & Antibody Engineering
 
Aditya Monoclonal Antibodies
Aditya Monoclonal AntibodiesAditya Monoclonal Antibodies
Aditya Monoclonal Antibodies
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 

Similar to Monoclonal antibodies stem cell 2018

Monoclonal antibodies and stem cell
Monoclonal antibodies and stem cellMonoclonal antibodies and stem cell
Monoclonal antibodies and stem cellAhmed Abdellatif
 
Monoclonal antibody production
Monoclonal antibody productionMonoclonal antibody production
Monoclonal antibody productionSrilaxmiMenon
 
256447 stem-cell-transplantation
256447 stem-cell-transplantation256447 stem-cell-transplantation
256447 stem-cell-transplantationYoAmoNYC
 
256447 stem-cell-transplantation
256447 stem-cell-transplantation256447 stem-cell-transplantation
256447 stem-cell-transplantationabctutor
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyHasnat Tariq
 
Stem cell therapy
Stem cell therapyStem cell therapy
Stem cell therapyMika Ghosh
 
Stem cell technology | Presented by pranjali V. Bhadane
Stem cell technology | Presented by pranjali V. BhadaneStem cell technology | Presented by pranjali V. Bhadane
Stem cell technology | Presented by pranjali V. Bhadanepranjali bhadane
 
autologous bone marrow transplant
autologous bone marrow transplantautologous bone marrow transplant
autologous bone marrow transplantAnam Khurshid
 
#1 principles of tissue engineering
#1 principles of tissue engineering#1 principles of tissue engineering
#1 principles of tissue engineeringRoshan Shetty
 
Stem cells and regenerative medicine
Stem cells and regenerative medicineStem cells and regenerative medicine
Stem cells and regenerative medicineJibanjyotiDas2
 
Stem cell therapy
Stem cell therapyStem cell therapy
Stem cell therapyKarun Kumar
 
Stem cell and its clinical implications
Stem cell and its clinical implicationsStem cell and its clinical implications
Stem cell and its clinical implicationsDRx.Yogesh Chaudhari
 
Monoclonal Antibodies Hybridoma Technique
Monoclonal Antibodies Hybridoma Technique  Monoclonal Antibodies Hybridoma Technique
Monoclonal Antibodies Hybridoma Technique Iqbal Ahmed Rana
 
Hybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibodyHybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibodyRajpal Choudhary
 
“Stem Cell, Possibilities And Utility In Health sector”
“Stem Cell, Possibilities And Utility In Health sector” “Stem Cell, Possibilities And Utility In Health sector”
“Stem Cell, Possibilities And Utility In Health sector” Ajit Tiwari
 
Bone marrow transplantation
Bone marrow transplantationBone marrow transplantation
Bone marrow transplantationsuchitkumar24
 
Stem cells technology and applications
Stem cells technology and applicationsStem cells technology and applications
Stem cells technology and applicationszuharahman2
 
Inman_Stem_Cells_05
Inman_Stem_Cells_05Inman_Stem_Cells_05
Inman_Stem_Cells_05pharmdude
 

Similar to Monoclonal antibodies stem cell 2018 (20)

Monoclonal antibodies and stem cell
Monoclonal antibodies and stem cellMonoclonal antibodies and stem cell
Monoclonal antibodies and stem cell
 
Monoclonal antibody production
Monoclonal antibody productionMonoclonal antibody production
Monoclonal antibody production
 
256447 stem-cell-transplantation
256447 stem-cell-transplantation256447 stem-cell-transplantation
256447 stem-cell-transplantation
 
256447 stem-cell-transplantation
256447 stem-cell-transplantation256447 stem-cell-transplantation
256447 stem-cell-transplantation
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technology
 
Stem cell therapy
Stem cell therapyStem cell therapy
Stem cell therapy
 
Stem cell technology | Presented by pranjali V. Bhadane
Stem cell technology | Presented by pranjali V. BhadaneStem cell technology | Presented by pranjali V. Bhadane
Stem cell technology | Presented by pranjali V. Bhadane
 
autologous bone marrow transplant
autologous bone marrow transplantautologous bone marrow transplant
autologous bone marrow transplant
 
#1 principles of tissue engineering
#1 principles of tissue engineering#1 principles of tissue engineering
#1 principles of tissue engineering
 
Stem cells and regenerative medicine
Stem cells and regenerative medicineStem cells and regenerative medicine
Stem cells and regenerative medicine
 
Stem cell therapy
Stem cell therapyStem cell therapy
Stem cell therapy
 
Stem cell and its clinical implications
Stem cell and its clinical implicationsStem cell and its clinical implications
Stem cell and its clinical implications
 
Monoclonal Antibodies Hybridoma Technique
Monoclonal Antibodies Hybridoma Technique  Monoclonal Antibodies Hybridoma Technique
Monoclonal Antibodies Hybridoma Technique
 
Hybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibodyHybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibody
 
“Stem Cell, Possibilities And Utility In Health sector”
“Stem Cell, Possibilities And Utility In Health sector” “Stem Cell, Possibilities And Utility In Health sector”
“Stem Cell, Possibilities And Utility In Health sector”
 
Overview of Stem Cell
Overview of Stem CellOverview of Stem Cell
Overview of Stem Cell
 
Bone marrow transplantation
Bone marrow transplantationBone marrow transplantation
Bone marrow transplantation
 
Stem cells technology and applications
Stem cells technology and applicationsStem cells technology and applications
Stem cells technology and applications
 
Inman_Stem_Cells_05
Inman_Stem_Cells_05Inman_Stem_Cells_05
Inman_Stem_Cells_05
 
Arsh copy
Arsh   copyArsh   copy
Arsh copy
 

More from Ahmed Abdellatif

Hormone and Enzyme (Description and synthesis)
Hormone and Enzyme (Description and synthesis)Hormone and Enzyme (Description and synthesis)
Hormone and Enzyme (Description and synthesis)Ahmed Abdellatif
 
Conventional and genomic vaccines
Conventional and genomic vaccinesConventional and genomic vaccines
Conventional and genomic vaccinesAhmed Abdellatif
 
Dna cloning final 11.11.2018
Dna cloning  final 11.11.2018Dna cloning  final 11.11.2018
Dna cloning final 11.11.2018Ahmed Abdellatif
 
Source of Microbes & Enzyme Immobilization
Source of Microbes & Enzyme ImmobilizationSource of Microbes & Enzyme Immobilization
Source of Microbes & Enzyme ImmobilizationAhmed Abdellatif
 
Conventional and genomic vaccines
Conventional and genomic vaccinesConventional and genomic vaccines
Conventional and genomic vaccinesAhmed Abdellatif
 

More from Ahmed Abdellatif (8)

Introduction to Biotech
Introduction to BiotechIntroduction to Biotech
Introduction to Biotech
 
Hormone and Enzyme (Description and synthesis)
Hormone and Enzyme (Description and synthesis)Hormone and Enzyme (Description and synthesis)
Hormone and Enzyme (Description and synthesis)
 
Microbial growth stages
Microbial growth stagesMicrobial growth stages
Microbial growth stages
 
Bioinformatics
BioinformaticsBioinformatics
Bioinformatics
 
Conventional and genomic vaccines
Conventional and genomic vaccinesConventional and genomic vaccines
Conventional and genomic vaccines
 
Dna cloning final 11.11.2018
Dna cloning  final 11.11.2018Dna cloning  final 11.11.2018
Dna cloning final 11.11.2018
 
Source of Microbes & Enzyme Immobilization
Source of Microbes & Enzyme ImmobilizationSource of Microbes & Enzyme Immobilization
Source of Microbes & Enzyme Immobilization
 
Conventional and genomic vaccines
Conventional and genomic vaccinesConventional and genomic vaccines
Conventional and genomic vaccines
 

Recently uploaded

Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticscarlostorres15106
 
Unlocking the Potential of the Cloud for IBM Power Systems
Unlocking the Potential of the Cloud for IBM Power SystemsUnlocking the Potential of the Cloud for IBM Power Systems
Unlocking the Potential of the Cloud for IBM Power SystemsPrecisely
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptxLBM Solutions
 
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr LapshynFwdays
 
Pigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping ElbowsPigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping ElbowsPigging Solutions
 
Unblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen FramesUnblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen FramesSinan KOZAK
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationSafe Software
 
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024BookNet Canada
 
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...Patryk Bandurski
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationSlibray Presentation
 
Breaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path MountBreaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path MountPuma Security, LLC
 
APIForce Zurich 5 April Automation LPDG
APIForce Zurich 5 April  Automation LPDGAPIForce Zurich 5 April  Automation LPDG
APIForce Zurich 5 April Automation LPDGMarianaLemus7
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubKalema Edgar
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
Benefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other FrameworksBenefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other FrameworksSoftradix Technologies
 
Enhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for PartnersEnhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for PartnersThousandEyes
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupFlorian Wilhelm
 
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 3652toLead Limited
 
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking MenDelhi Call girls
 

Recently uploaded (20)

Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
 
Unlocking the Potential of the Cloud for IBM Power Systems
Unlocking the Potential of the Cloud for IBM Power SystemsUnlocking the Potential of the Cloud for IBM Power Systems
Unlocking the Potential of the Cloud for IBM Power Systems
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptx
 
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
 
Pigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping ElbowsPigging Solutions Piggable Sweeping Elbows
Pigging Solutions Piggable Sweeping Elbows
 
Unblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen FramesUnblocking The Main Thread Solving ANRs and Frozen Frames
Unblocking The Main Thread Solving ANRs and Frozen Frames
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
 
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
 
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
Integration and Automation in Practice: CI/CD in Mule Integration and Automat...
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck Presentation
 
Breaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path MountBreaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path Mount
 
APIForce Zurich 5 April Automation LPDG
APIForce Zurich 5 April  Automation LPDGAPIForce Zurich 5 April  Automation LPDG
APIForce Zurich 5 April Automation LPDG
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding Club
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
Benefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other FrameworksBenefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other Frameworks
 
Enhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for PartnersEnhancing Worker Digital Experience: A Hands-on Workshop for Partners
Enhancing Worker Digital Experience: A Hands-on Workshop for Partners
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project Setup
 
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
 
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
 
Vulnerability_Management_GRC_by Sohang Sengupta.pptx
Vulnerability_Management_GRC_by Sohang Sengupta.pptxVulnerability_Management_GRC_by Sohang Sengupta.pptx
Vulnerability_Management_GRC_by Sohang Sengupta.pptx
 

Monoclonal antibodies stem cell 2018

  • 1.
  • 2.
  • 3. Any of the highly specific antibodies produced in lar ge quantity by the clones of a single hybridoma cell. Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies have monovalent affinity, in that they bind to the same epitope.
  • 4.  Antibodies have important uses beyond fighting infections in the body.  Production of long-lasting monoclonal antibodies is a recent invention and it is used in both medicine and research.  Monoclonal Antibody: a stable antibody which can be used over a period of time
  • 5. 1. Inject a mouse with a specific antigen to stimulate its immune system to produce necessary antibodies. 2. Extract mouse spleen cells (containing B- lymphocytes) and culture them in the lab. 3. Extract mouse tumour cells, which grow continuously, and culture them in the lab. 4. Mix spleen cells and tumour cells on the same plate and culture.
  • 6. 5. Add polyethylene glycol – this causes some B- lymphocytes to fuse with tumour cells to produce a hybrid cell called a hybridoma. 6. Grow the cells under conditions that allow only hybridoma cells to survive. 7. Extract the cells, culture them separately and test the medium around each cell for the specific antibody of interest. 8. Culture the cells making the desired antibody and use as needed.
  • 7.
  • 8.  The previous picture is showing a mouse being immunized against a target cell “X”. This will allow the mouse to produce antibodies for that will target against the “X” antigen.  Once the mouse has formed antibodies to the “X” antigen the cells are then isolated in the mouse’s spleen. Monoclonal antibodies are produced by fusing single antibody-forming cells to tumor cells grown in culture. The resulting cell is called a hybridoma. Hybridoma cells are continuously growing cell line generated by the fusion of a myeloma cell and a normal cell that are capable of producing antibodies.  Each hybridoma will produce relatively large quantities of identical antibody molecules. Because the hybridoma is multiplying in culture, it is possible to produce a population of cells, each is producing identical antibody molecules. These antibodies are called "monoclonal antibodies" because they are produced by the identical offspring of a single, cloned antibody producing cell.
  • 9.  A pregnant woman has the hormone human chorionic gonadotrophin (HCG) in her urine.  Monoclonal antibodies to HCG have been produced. These have been attached to enzymes which can later interact with a dye molecule and produce a color change.
  • 10.  Pregnancy test contains three regions – reaction region, test region and control region ◦ Reaction region: contains monoclonal anti-HCG antibodies linked to enzyme ◦ Test region: contains polyclonal anti-HCG antibodies, which will bind to HCG molecules bound to monoclonal anti-HCG antibodies. Also contains dye molecules which will be activated if monoclonal antibodies bind to polyclonal anti-HCG antibodies ◦ Control region: contains anti-mouse antibodies and dye molecules which will be activated if monoclonal antibodies bind here
  • 11.  When pregnant woman’s urine travels up the pregnancy test, HCG will bind to monoclonal antibodies in reaction region  Movement of the urine will move the monoclonal antibodies up to the test region  Monoclonal antibodies with bound HCG will bind to antibodies in test region and activate dye molecules, producing a colour change  Any unbound monoclonal antibodies will continue to travel to control region and will bind to anti-mouse antibodies, activating dye molecules and producing a colour change
  • 12.
  • 13.  The test of HIV infection is based on detecting the presence of HIV antibody in the patient’s blood serum.
  • 14. a) HIV antigen is attached to the plate. b) Patients serum passed over the plate. Any HIV antibody in the patients serum will be attached to the antigen already on the plate. c) A second antibody which is specific to the HIV antibody is passed over the plate. This antibody will attach to the concentrated HIV antibody on the plate. This second antibody has an enzyme attached to its structure. d) Chromogen dye is passed over the complex of concentrated HIV antibody/conjugated antibody. e) The enzyme will turn the chromogen to a more intense color. The more intense the color, the greater the HIV antibody level. This would be the a positive result for a HIV test.
  • 15.  Cancer cells carry specific tumour-associated antigens (TAA) on their plasma membrane.  Monoclonal anti-TAA antibodies have been produced.  Drugs which kill tumour cells or inhibit key proteins in tumour cells are attached to monoclonal anti-TAA antibodies.  Cancer cells are specifically targeted, avoiding damage to healthy host cells.
  • 16.  Many patients develop the immune response to monoclonal antibodies produced in mice, as these are foreign proteins.  Genetically engineered antibodies are being perfected to avoid triggering the immune response.
  • 18. 1998 - Researchers first extract stem cells from human embryos 1999 - First Successful human transplant of insulin-making cells from cadavers 2001 - President Bush restricts federal funding for embryonic stem-cell research 2002 - Juvenile Diabetes Research Foundation International creates $20 million fund-raising effort to support stem-cell research 2002 - California ok stem cell research 2004 - Harvard researchers grow stem cells from embryos using private funding 2004 - Ballot measure for $3 Billion bond for stem cells Stem Cell History
  • 19.  A cell that has the ability to continuously divide and differentiate (develop) into various other kind(s) of cells/tissues
  • 20.  ‘Blank cells’ (unspecialized)  Capable of dividing and renewing themselves for long periods of time (proliferation and renewal)  Have the potential to give rise to specialized cell types (differentiation)
  • 21. Stem cell type Description Examples Totipotent Each cell can develop into a new individual Cells from early (1-3 days) embryos Pluripotent Cells can form any (over 200) cell types Some cells of blastocyst (5 to 14 days) Multipotent Cells differentiated, but can form a number of other tissues Fetal tissue, cord blood, and adult stem cells
  • 22. This cell Can form the Embryo and placenta This cell Can just form the embryo Fully mature
  • 23.
  • 24.  Multipotent stem cells – limited in what the cells can become
  • 26.
  • 27. Why do researchers study embryonic stem cells?  Tissue-specific stem cells are limited in their differentiation potential (blood  blood)  Stem cells from some tissues are inaccessible  Some tissue-specific stem cells don’t self-renew well  Some tissues may not have stem cells!
  • 28. blastocyst Blastocyst inner mass cells 8-cell stagecleavage
  • 29.
  • 30.  Skin  Fat Cells  Bone marrow  Brain  Many other organs & tissues Adult Stem Cells An undifferentiated cells found among specialized or differentiated cells in a tissue or organ after birth
  • 32.  Found in spongy bone where blood cells form  Used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells.  treat patients diagnosed with leukemia, aplastic anemia, and lymphomas  Need a greater histological immunocompatibility
  • 34.  Also Known as Wharton’s Jelly  Adult stem cells of infant origin  Less invasive than bone marrow  Greater compatibility  Less expensive
  • 35. Three important functions: 1. Plasticity: Potential to change into other cell types like nerve cells 2. Homing: To travel to the site of tissue damage 3. Engraftment: To unite with other tissues
  • 36. Stem Cell Applications • Tissue repair - nerve, heart, muscle, organ, skin • Cancers • Autoimmune diseases - diabetes, rheumatoid arthritis, MS
  • 37. Tissue Repair • Regenerate spinal cord, heart tissue or any other major tissue in the body.
  • 38. Heart Disease • Adult bone marrow stem cells injected into the hearts are believed to improve cardiac function in victims of heart failure or heart attack
  • 39. Leukemia and Cancer • Studies show leukemia patients treated with stem cells emerge free of disease. • Injections of stem cells have also reduces pancreatic cancers in some patients. Proliferation of white cells
  • 40. Rheumatoid Arthritis • Adult Stem Cells may be helpful in jumpstarting repair of eroded cartilage.
  • 41. Type I Diabetes • Pancreatic cells do not produce insulin • Embryonic Stems Cells might be trained to become pancreatic islets cells needed to secrete insulin.
  • 42. • Differentiation of stem cells into mature, functional cells • Potential for tumor formation • Immune rejection
  • 43.  Embryonic Stem cells are derived from extra blastocysts that would otherwise be discarded following IVF.  Extracting stem cells destroys the developing blastocyst (embryo).  Questions for Consideration-  Is an embryo a person?  Is it morally acceptable to use embryos for research?  When do we become “human beings?”